Abstract
KCNJ11 gene mutations are related to permanent neonatal diabetes mellitus (PNDM). Glycemic stability minimizes the risk of complications. Sulfonylureas (SU) are the proven best therapeutic option. We report a 18-month follow-up of switching from insulin to SU in a mother and her daughter with PNDM due to KCNJ11 mutation.
Original language | English |
---|---|
Journal | Diabetes Research and Clinical Practice |
Volume | 94 |
Issue number | 2 |
DOIs | |
Publication status | Published - Nov 2011 |
Keywords
- KCNJ11
- PNDM treatment
- Sulfonylureas
- Switch to SU
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Internal Medicine
- Endocrinology